rs2853579 — ABCA1

ABCA1 rs2853579 — A Common Regulatory Tag in the HDL Biogenesis Gene

ABCA1¹¹ ATP-Binding Cassette Transporter A1 — a cell-membrane pump that loads cholesterol and phospholipids onto lipid-poor apolipoprotein A-I, forming nascent HDL particles is the primary gatekeeper of reverse cholesterol transport²² reverse cholesterol transport
the pathway by which peripheral tissues offload excess cholesterol back to the liver for processing and excretion. Without ABCA1, cells cannot shed excess cholesterol and HDL formation collapses. Loss-of-function mutations in both copies cause Tangier disease³³ Tangier disease
a rare autosomal recessive disorder with near-absent HDL, cholesterol-laden macrophage deposits, and accelerated atherosclerosis. rs2853579 operates at a far subtler level — it is a common synonymous coding variant within ABCA1 exon 15 whose effect on HDL arises not from any protein change but from its co-inheritance with nearby regulatory variation that modulates how much ABCA1 the liver produces.

The Mechanism

rs2853579 sits at chr9:104,828,991 (GRCh38) within the coding sequence of ABCA1 at transcript position c.2040 on NM_005502.4. The ABCA1 gene is transcribed from the minus strand; genome files report the plus strand, where the reference allele is G and the minor allele is T. The G>T change corresponds to a C>A substitution on the coding strand — an ATC→ATA codon change that encodes isoleucine at position 680 in both cases (p.Ile680Ile). This synonymous⁴⁴ synonymous
a variant that changes the DNA sequence but not the resulting amino acid — sometimes called a "silent" mutation variant therefore cannot alter ABCA1 protein function directly. Any influence on HDL-C must arise through linkage disequilibrium⁵⁵ linkage disequilibrium
LD — the tendency for nearby alleles to be inherited together; a tag SNP statistically "marks" a causal variant nearby without being functionally responsible itself with a causal regulatory element.

The ABCA1 locus contains several intronic enhancers governing hepatic expression. Richardson et al.⁶⁶ Richardson et al.
Richardson et al. Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism. PLOS One, 2019 identified that the intronic variant rs2575875 creates an allele-specific STAT3⁷⁷ Signal Transducer and Activator of Transcription 3 — a transcription factor that activates gene expression in response to cytokines and growth factors in the liver binding site that loops physically to the ABCA1 promoter and drives hepatic transporter expression. Multiple GWAS tag SNPs across the ABCA1 locus — including rs4149268, rs1883025, and rs2853579 — show overlapping HDL-C associations consistent with tagging the same or related regulatory haplotype. The G allele of rs2853579 marks the lower-expression haplotype; the T allele marks the higher-expression haplotype.

The Evidence

The association was identified in a large EHR-based GWAS⁸⁸ EHR-based GWAS
Hoffmann TJ et al. A large electronic-health-record-based genome-wide study of serum lipids. Nature Genetics, 2018 of 94,674 ancestrally diverse Kaiser Permanente participants using longitudinal untreated lipid measurements. rs2853579-G was associated with decreased HDL-C (β = −0.046 mmol/L, p = 6×10⁻¹⁶) and decreased total cholesterol (β = −0.053 mmol/L, p = 1×10⁻¹⁹) at genome-wide significance. A second analysis from the same dataset found p = 2×10⁻²⁰ for HDL-C with β = −0.044 mmol/L per G allele — equivalent to roughly −1.7 mg/dL per allele. For context, typical HDL-C ranges from 40 to 80 mg/dL, so the per-allele effect is modest but statistically robust and biologically coherent.

Population frequencies from gnomAD show remarkable ancestry variation: the T allele (higher HDL) is rare in Europeans (~12%) and South Asians (~15%) but reaches 66% in East Asian populations and 45% in African populations. In East Asia, T is the major allele — meaning the lower-HDL GG genotype is actually the minor one in that ancestry. ClinVar classifies this variant as benign for Tangier disease and hypoalphalipoproteinemia, consistent with the GWAS data showing small common-variant effects rather than the large functional disruptions that characterize those disorders.

Practical Actions

For most carriers of the common GG genotype (~73% of the global population), this variant represents the population-typical baseline for ABCA1-driven HDL production. The most actionable information at this locus is your measured HDL-C. The per-allele effect of ~1.7 mg/dL for the T allele translates to approximately +3.4 mg/dL for TT homozygotes — a meaningful directional tendency but one that is easily matched or exceeded by lifestyle factors: regular aerobic exercise raises HDL by 3–6 mg/dL in most people; eliminating trans fats adds 2–4 mg/dL; replacement of saturated fat with monounsaturated fat (olive oil, avocado, nuts) provides additional benefit.

Carriers of the rare TT genotype (~2% in Europeans, ~44% in East Asians) have a genetically favorable signal at this locus. Confirmed low HDL despite the favorable TT genotype would warrant a broader workup of other lipid-modifying variants, dietary patterns, and metabolic factors.

Interactions

rs2853579 sits within the same ABCA1 gene as rs4149268 and rs1883025, two other intronic variants previously associated with HDL-C in GWAS. Whether they represent independent regulatory signals or partial correlates of the same haplotype has not been fully resolved at the individual-study level. The R219K missense variant (rs2230806, ABCA1) alters protein-level cholesterol efflux capacity through a distinct mechanism from regulatory tag SNPs and represents an independent functional layer. Carriers of other low-HDL variants — such as CETP (rs708272) or LIPC variants — can compound the rs2853579 G-allele effect through additive lipid pathway disruption.